Sunitinib induces macrophage dysfunction and impaired tissue regeneration through suppression of PPARγ
BackgroundSunitinib is a widely used multi-target tyrosine kinase inhibitor associated with side effects that may impair tissue repair and regeneration, potentially contributing to the onset of medication-related osteonecrosis of the jaw. Macrophages p…